HCLSoftware is doubling down on digital sovereignty with the launch of HCL Domino 14.5, its latest upgrade to the long-standing enterprise collaboration suite. The update includes Domino IQ, a sovereign AI extension designed to give organizations precise control over how artificial intelligence interacts with sensitive data—without defaulting to foreign-owned cloud services.
RealSense, the longtime Intel division behind some of the most widely used 3D vision systems in robotics, has officially spun out into a standalone company—and it’s hitting the ground running with $50 million in fresh Series A funding.
Named Best AI Voice Generator of 2025 by Software Experts, Epidemic Sound’s entry into the voice AI race is turning heads for all the right reasons: studio-quality output, intuitive design, ethical AI practices, and real human voices at its core. In an industry where synthetic speech often still sounds… well, synthetic, this is a meaningful shift.
Cloudian, known for its ultra-scalable object storage, is now fusing that storage power with AI inferencing capabilities—all in one platform. The result? A unified solution that eliminates the traditional bottlenecks between storing vast vector datasets and running real-time AI workloads like recommendations, NLP, and RAG (retrieval-augmented generation).
Worldwide end-user spending on generative AI (GenAI) models is projected to total $14.2 billion in 2025, according to Gartner, Inc. End-user spending on specialized GenAI models, which include domain-specific language models (DSLMs), is estimated to total $1.1 billion in 2025 (see Table 1).
Allyant, a longtime heavyweight in the digital accessibility space, just took a major leap forward. Its flagship product, CommonLook PDF, is now available as a web-based, AI-enhanced platform, expanding access and significantly reducing the skill barrier for remediating inaccessible PDFs—still one of the biggest thorns in the side of digital compliance.
In the high-stakes world of drug safety, speed and accuracy aren’t just nice to have—they’re life-critical. That’s why Boehringer Ingelheim, one of the largest pharma players globally, is betting big on AI to overhaul its pharmacovigilance operations. The company just rolled out LifeSphere® NavaX™, ArisGlobal’s GenAI-powered automation platform, to streamline how it processes individual case safety reports (ICSRs)—a fundamental, yet historically labor-intensive, part of drug safety.
Most AI deployments today get stuck somewhere between proof of concept and pilot purgatory. Tredence, a data science and AI consultancy, wants to change that—and fast. The company just released its Agentic AI Playbook, a strategic guide aimed at Chief Data & Analytics Officers (CDAOs) and AI leaders looking to scale artificial intelligence beyond experiments and into enterprise-wide operations.
In a move designed to meet the growing complexity of AI development head-on, Clarifai has introduced AI Runners, a powerful new tool that lets developers run and serve AI models from virtually anywhere—local machines, private servers, or on-prem clusters—while still tapping into the full muscle of Clarifai’s cloud-based AI platform.
